Intravascular Ultrasound Market Size & Growth Forecast 2027–2036, By Segments (Product, Modality, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Intravascular Ultrasound Market size was around USD 932.4 million in 2026 and is slated to grow at a 4.85% CAGR from 2027 to 2036, attaining USD 1.5 billion by 2036. The industry revenue for 2027 is estimated at USD 970.44 million.
Get more details on this report
Request Free Sample ReportIntravascular Ultrasound Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 47.81% market share in 2026, supported by established interventional cardiology infrastructure, widespread imaging-guided procedures, specialized hospitals, and experienced physicians driving consistent clinical adoption.
- Asia Pacific is projected to grow at a 5.99% CAGR, fueled by rising minimally invasive cardiovascular procedures, expanding cath lab capabilities, and broader adoption of advanced imaging technologies.
Segment Momentum
- Accessories held a 59.85% market share in 2026 and also recorded the fastest growth, driven by their routine, repeat-use nature in IVUS-guided procedures that creates steady demand linked to procedure volumes.
- iMAP IVUS is the fastest-growing modality as providers increasingly seek more refined tissue characterization and imaging interpretation to support better procedural decision-making during catheter-based interventions.
Market Expansion Drivers
- Rising global cardiovascular disease prevalence increasing demand for advanced intravascular imaging diagnostics.
- Shift toward minimally invasive cardiac procedures accelerating adoption of intravascular ultrasound systems.
- Advancements in imaging resolution and reimbursement support expanding clinical adoption of IVUS technology.
Leading Market Participants
- Major players in the intravascular ultrasound market include Boston Scientific Corporation (United States), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), Samsung Medison Co., Ltd. (South Korea), Hitachi, Ltd. (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), CHISON Medical Technologies Co., Ltd. (China).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 932.4 million
- 2027 Estimated Market Size: USD 970.44 million.
- Projected Market Size: USD 1.5 billion by 2036
- Growth Forecast: 4.85% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Accessories (Product) | Virtual Histology IVUS (Modality) | Hospitals (End Use)
- Emerging Opportunity Segment: Accessories (Product) | iMAP IVUS (Modality) | Diagnostic Imaging Centers (End Use)
Market Growth Drivers and Industry Trends
Rising global cardiovascular disease prevalence increasing demand for advanced intravascular imaging diagnostics
The growing prevalence of cardiovascular disease is supporting the intravascular ultrasound market by increasing clinical demand for diagnostic technologies that provide detailed visualization within blood vessels. As cardiovascular care requires more precise assessment of vascular conditions, advanced intravascular imaging can assist clinicians in evaluating vessel characteristics and supporting treatment decisions.
Shift toward minimally invasive cardiac procedures accelerating adoption of intravascular ultrasound systems
Increasing preference for minimally invasive cardiac interventions will propel the intravascular ultrasound market as healthcare providers adopt imaging technologies suited to catheter-based procedures. IVUS systems can provide real-time intravascular visualization during interventions, helping clinicians assess vessel conditions and guide procedural decisions without relying on more invasive approaches.
Advancements in imaging resolution and reimbursement support expanding clinical adoption of IVUS technology
Improved imaging resolution is enhancing the clinical value of the intravascular ultrasound market by enabling more detailed visualization during cardiovascular procedures. Alongside these technological improvements, reimbursement support can strengthen healthcare providers' willingness to incorporate IVUS into clinical workflows, particularly where imaging capabilities contribute to procedural assessment and treatment planning.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global cardiovascular disease prevalence increasing demand for advanced intravascular imaging diagnostics | 2.00% | High | North America, Europe, Asia Pacific | High | Near Term |
| Shift toward minimally invasive cardiac procedures accelerating adoption of intravascular ultrasound systems | 1.70% | High | North America, Europe | High | Near Term |
| Advancements in imaging resolution and reimbursement support expanding clinical adoption of IVUS technology | 1.40% | High | North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the intravascular ultrasound market, North America accounted for the largest share of 47.81% in 2026, reflecting the region's advanced cardiovascular care infrastructure, strong adoption of image-guided interventional procedures, and established clinical use of intravascular imaging technologies. The presence of specialized cardiac centers and a strong focus on minimally invasive treatment approaches support demand for technologies that enable detailed visualization of coronary vessels and improve procedural decision-making. Continued investment in healthcare infrastructure, physician training, and advanced diagnostic capabilities further strengthens adoption. Growing emphasis on personalized cardiovascular care and improved procedural outcomes also supports the region's sustained market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to experience the fastest regional expansion, supported by rising cardiovascular disease burden, improving healthcare infrastructure, and increasing access to advanced diagnostic and interventional technologies. Expanding hospital capabilities and greater adoption of minimally invasive cardiovascular procedures are creating new opportunities for intravascular ultrasound solutions. Healthcare modernization, increasing clinical awareness, and investments in specialized cardiac facilities are also improving the availability of advanced imaging technologies. As healthcare systems across the region strengthen their capacity for complex cardiovascular interventions, demand for precise intravascular imaging is likely to gain further momentum.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Imaging PrecisionGermany prioritizes intravascular ultrasound adoption in interventional cardiology through evidence-based clinical practices and advanced catheterization laboratories. Healthcare providers in Germany increasingly incorporate IVUS into routine vascular assessments to enhance treatment accuracy and procedural consistency.
France 🇫🇷
Advanced Cath Lab FocusFrance promotes intravascular ultrasound adoption through specialized cardiac centers investing in advanced catheterization technologies. Clinicians in France increasingly rely on IVUS to improve lesion characterization and guide appropriate vascular intervention strategies.
Italy 🇮🇹
Interventional Imaging ExpansionItaly continues strengthening intravascular ultrasound capabilities within hospitals performing complex coronary interventions. Healthcare providers in Italy increasingly integrate IVUS into procedural workflows to improve vessel visualization and support informed therapeutic decisions.
Japan 🇯🇵
Complex Lesion AssessmentJapan continues expanding the use of intravascular ultrasound for evaluating complex coronary lesions and optimizing minimally invasive procedures. Cardiology specialists in Japan emphasize high-resolution intravascular imaging to support individualized treatment strategies and improved procedural outcomes.
South Korea 🇰🇷
Technology-Driven CardiologySouth Korea combines advanced imaging platforms with modern cardiovascular care to expand intravascular ultrasound utilization. Healthcare providers in South Korea increasingly adopt IVUS-enabled interventions to strengthen procedural precision and support minimally invasive treatment approaches.
United States 🇺🇸
Image-Guided InterventionThe U.S. intravascular ultrasound market emphasizes precision-guided cardiovascular procedures supported by advanced imaging technologies. Hospitals and cardiac centers in the U.S. continue integrating IVUS into complex interventions to improve procedural planning and optimize clinical decision-making.
Segment Leadership and Growth Trends
Intravascular Ultrasound Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Accessories (Largest & Fastest-Growing Segment)
The accessories segment held the largest share of the intravascular ultrasound market in 2026 and is also the fastest-growing segment, supported by the essential role of complementary components in enabling effective intravascular imaging procedures. Accessories contribute to the functionality, compatibility, and procedural efficiency of IVUS systems, making them an integral part of clinical workflows. As physicians increasingly rely on intravascular imaging to assess vessel conditions and guide interventional procedures, demand for supporting components is expanding alongside system utilization. Continued emphasis on procedural accuracy, workflow efficiency, and reliable imaging performance further strengthens the segment's market position.
Modality Segment Analysis: Virtual Histology IVUS (Largest Segment) vs iMAP IVUS (Fastest-Growing Segment)
The virtual histology IVUS segment accounted for the largest share of the intravascular ultrasound market at 59.27% in 2026, reflecting its ability to provide additional information about plaque composition alongside conventional intravascular imaging. This capability can support clinicians in evaluating coronary lesions and understanding the characteristics of atherosclerotic plaque, strengthening its value in cardiovascular assessment and intervention planning. Increasing use of imaging technologies that provide more detailed lesion information is supporting demand for advanced IVUS modalities. Its established clinical utility and integration into diagnostic and interventional workflows contribute to the segment's leading position.
The iMAP IVUS segment is expected to record the fastest growth as demand increases for intravascular imaging technologies capable of providing detailed characterization of coronary plaque and vessel structures. Enhanced tissue characterization can support physicians in evaluating lesion composition and making more informed decisions during cardiovascular interventions. Continued technological development in intravascular imaging, together with increasing emphasis on precise lesion assessment, is creating favorable conditions for adoption. Greater clinical interest in advanced imaging capabilities is therefore supporting the expansion of iMAP IVUS applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Consoles, Accessories | Accessories | Accessories |
| Modality | Virtual Histology IVUS, iMAP IVUS, Integrated Backscatter IVUS | Virtual Histology IVUS | iMAP IVUS |
| End Use | Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes | Hospitals | Diagnostic Imaging Centers |
Competitive Landscape and Market Positioning
Prominent players in the intravascular ultrasound market:
1. Boston Scientific Corporation (United States)
2. Koninklijke Philips N.V. (Netherlands)
3. GE HealthCare Technologies Inc. (United States)
4. Siemens Healthineers AG (Germany)
5. Canon Medical Systems Corporation (Japan)
6. Fujifilm Holdings Corporation (Japan)
7. Samsung Medison Co. Ltd. (South Korea)
8. Hitachi Ltd. (Japan)
9. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
10. CHISON Medical Technologies Co. Ltd. (China)
Advancements in cardiovascular imaging are improving precision in vascular diagnostics and intervention planning. The intravascular ultrasound market is evolving through enhanced imaging resolution and real-time diagnostic capabilities. Continuous innovation is supporting better procedural accuracy and patient outcomes.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| GE HealthCare Technologies Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Fujifilm Holdings Corporation (Japan) | |||||||
| Samsung Medison Co. Ltd. (South Korea) | |||||||
| Hitachi Ltd. (Japan) | |||||||
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China) | |||||||
| CHISON Medical Technologies Co. Ltd. (China). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Stryker | May-26 | Stryker completed the acquisition of Amplitude Vascular Systems, which develops a next-generation intravascular lithotripsy (IVL) platform. The transaction expands Stryker’s vascular intervention portfolio by adding specialized technology designed to treat complex peripheral arterial disease, thereby increasing the company's operational footprint in image-guided endovascular procedures and competitive market share. |
| Conavi Medical | Apr-26 | Conavi Medical received U.S. FDA 510(k) clearance for its next-generation hybrid IVUS-OCT imaging system. The platform enables simultaneous, co-registered intravascular ultrasound and optical coherence tomography imaging in a single workflow, offering comprehensive coronary anatomy assessment. This regulatory milestone initiates the company’s preparations for a U.S. commercial market launch, targeted for the second half of 2026. |
| Philips | Jan-26 | Philips completed the acquisition of SpectraWAVE, a developer of AI-enabled enhanced vascular imaging and physiology assessment technologies. This acquisition integrates SpectraWAVE's HyperVue imaging and angio-based fractional flow reserve (FFR) capabilities into Philips' diagnostic and treatment portfolio, strengthening its competitive positioning in high-definition coronary artery visualization and image-guided therapeutic interventions. |
| Evident Vascular | Jan-26 | Evident Vascular continues to advance the development of its AI-powered intravascular ultrasound platform following initial series funding. The company’s focus on integrating algorithmic image enhancements with high-resolution catheter hardware aims to address clinical limitations in peripheral vascular diagnostics, positioning the startup to compete in the growing market for image-guided vascular interventions. |
| Provisio Medical | Apr-24 | Provisio Medical received FDA 510(k) clearance for the Provisio SLT IVUS System, which integrates intravascular imaging with support-crossing catheter functionality. This technology is strategically designed to simplify vessel measurement procedures and improve clinical workflow efficiency, facilitating broader adoption of IVUS-guided interventions within peripheral vascular applications. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Intravascular Ultrasound Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Indication | Coronary Artery Disease, Peripheral Artery Disease, Stent Optimization, Complex Lesion Assessment |
| Procedure Type | Percutaneous Coronary Intervention, Diagnostic Angiography, Peripheral Vascular Intervention, Other Interventional Procedures |
| Vessel Type | Coronary Arteries, Peripheral Arteries, Renal Arteries, Other Vascular Beds |
Intravascular Ultrasound Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Opportunity Assessment |
|
| Hospital Procurement Decision Analysis |
|
| Reimbursement and Healthcare Economics |
|
Need a different cut of the data?
Request Custom ResearchHow much is the intravascular ultrasound market worth?
How will the intravascular ultrasound industry grow in terms of size and CAGR by 2036?
How is rising cardiovascular disease burden influencing adoption of IVUS in hospital procurement strategies?
How is the shift toward minimally invasive cardiac procedures shaping IVUS utilization?
Why do accessories lead the intravascular ultrasound market?
Which IVUS modality is gaining adoption the fastest?
Why does North America lead the intravascular ultrasound market?
Why is Asia Pacific the fastest-growing region in the intravascular ultrasound market?
What are the key competitors in the intravascular ultrasound landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization